UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): October 20, 2005


                            HealthSouth Corporation
                            -----------------------
             (Exact Name of Registrant as Specified in its Charter)

                                    Delaware
                                    --------
                 (State or Other Jurisdiction of Incorporation)


              1-10315                                 63-0860407
              -------                                 ----------
      (Commission File Number)             (IRS Employer Identification No.)


               One HealthSouth Parkway, Birmingham, Alabama 35243
               --------------------------------------------------
          (Address of Principal Executive Offices, Including Zip Code)


                                 (205) 967-7116
                                 --------------
              (Registrant's Telephone Number, Including Area Code)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]   Written communications pursuant to Rule 425 under the Securities Act 
      (17 CFR 230.425)

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act 
      (17 CFR 240.14a-12)

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the 
      Exchange Act (17 CFR 240.14d-2(b))

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the 
      Exchange Act (17 CFR 240.13e-4(c))
      



ITEM 1.01. Entry into a Material Definitive Agreement.

           (a)    Robert P. May Restricted Stock Award

                  As announced by HealthSouth Corporation on our Current Report
on Form 8-K dated September 6, 2005, Robert P. May resigned from the
HealthSouth Board of Directors and as Chairman of the Board of Directors,
effective October 1, 2005. As previously reported, HealthSouth granted to Mr.
May, 26,270 shares of restricted common stock (the "Subject Shares") pursuant
to the terms of an individual restricted stock agreement, dated March 1, 2005,
between HealthSouth and Mr. May which is filed as Exhibit 10 to our Current
Report on Form 8-K dated March 1, 2005 (the "Restricted Stock Agreement"). The
Subject Shares granted to Mr. May pursuant to the Restricted Stock Agreement
were subject to certain restrictions on transfer and events of forfeiture if
Mr. May ceased to be a member of the HealthSouth Board of Directors.

                  On October 20, 2005, in recognition of Mr. May's valuable
service and dedication to HealthSouth and its Board of Directors, the Special
Committee of the Board of Directors approved the removal of all of the
restrictions on transfer (other than those relating to the federal securities
laws) and forfeiture provisions under the Restricted Stock Agreement such that
all Subject Shares have vested and all restrictions upon transfer applicable to
such Subject Shares (other than those relating to the federal securities laws)
have terminated.

                  Finance Committee

                  As previously reported in HealthSouth's Annual Report on
Form 10-K for the fiscal years ended December 31, 2003 and 2002, filed with the
SEC on June 27, 2005, HealthSouth's directors receive an annual cash retainer
of $45,000 plus $2,000 per Board of Directors or Special Committee of the Board
of Directors meeting attended in person, $1,000 per meeting attended by
telephone, and $1,000 per committee meeting attended. Currently, the chair of
the Audit Committee receives an additional $25,000 per year, the chair of the
Compensation Committee receives an additional $15,000 per year, and the chairs
of the Corporate Compliance Committee and the Nominating/Corporate Governance
Committee each receive an additional $10,000 per year.

                  On October 20, 2005, the Special Committee of the Board of
Directors determined that the chair of the Finance Committee, which is
responsible for assisting the Board of Directors in the oversight of the use
and development of HealthSouth's financial resources, receive an additional
$10,000 per year. Steven R. Berrard is currently the chair of the Finance
Committee.



                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Current Report on Form 8-K to be signed on
its behalf by the undersigned hereunto duly authorized.

                                     HealthSouth Corporation


                                     By: /s/ Gregory L. Doody
                                        -------------------------------------
                                        Name:  Gregory L. Doody
                                        Title: Executive Vice President,
                                               General Counsel and Secretary


Dated:  October 25, 2005